Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage

Clinical trial NCT04857632 · UNKNOWN

Trial details

NCT number: NCT04857632
Sponsor: Capital Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Intracerebral Hemorrhage Statins

Start date: 2021-08-06
Primary completion: 2024-06-30
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.